Literature DB >> 12536092

Pulmonary hilar lymph nodes in lung cancer: assessment with 3D-dynamic contrast-enhanced MR imaging.

Ichiro Hasegawa1, Keisuke Eguchi, Ehiichi Kohda, Yutaka Tanami, Toru Mori, Hiroto Hatabu, Sachio Kuribayashi.   

Abstract

PURPOSE: We performed 3D-dynamic MRI on patients with primary lung cancer to identify its usefulness for detecting hilar adenopathy shown at surgery. METHODS AND MATERIALS: 30 consecutive patients with peripheral lung cancer underwent preoperative 3D-dynamic Gd-DTPA-enhanced MRI. Two thoracic radiologists blinded to histopathologic findings reviewed those studies independently for hilar adenopathy visualization. The results were correlated with surgical and histopathologic findings. Interreader agreement for the detection of hilar adenopathy was assessed by means of the kappa statistic.
RESULTS: Dynamic MRI demonstrated hilar adenopathy, with or without metastasis revealed at surgery, in all of 15 patients. Adenopathy without metastasis was shown in four patients. Dynamic MRI also revealed metastatic adenopathy in 11 of 12 patients with pathologically proven metastasis. There was only one case with lymph node metastasis that did not have adenopathy either on MRI or even at surgery. The diagnostic accuracy of dynamic MRI for adenopathy with or without metastases revealed at surgery were as follows; sensitivity, 100%; specificity, 100%; positive predictive value, 100%; and negative predictive value, 100%, respectively. The diagnostic accuracy of dynamic MRI for hilar lymph nodes metastasis were as follows; sensitivity, 92%; specificity, 78%; positive predictive value, 73%; and negative predictive value, 93%. Interreader agreement was substantial (kappa=0.73) for detection of hilar adenopathy.
CONCLUSION: Hilar adenopathy on 3D-dynamic MRI correlated well with that of surgical finding on patients with primary lung cancer. It may have the potential to make an accurate preoperative evaluation of hilar lymph node metastasis from lung cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12536092     DOI: 10.1016/s0720-048x(02)00056-6

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  2 in total

Review 1.  Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Yuanyuan Zhang; Qin Qin; Baosheng Li; Juan Wang; Kun Zhang
Journal:  Thorac Cancer       Date:  2015-01-08       Impact factor: 3.500

2.  Low-dose hilar and mediastinal stereotactic body radiation therapy for non-small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment.

Authors:  Roman O Kowalchuk; Michael R Waters; Martin Richardson; Kelly Spencer; James M Larner; Charles R Kersh
Journal:  Thorac Cancer       Date:  2020-05-29       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.